Skip to content

A randomized, controlled, multicenter clinical study on the treatment of cancer-related fatigue in patients with digestive tract tumors after chemotherapy using Baixiao moxibustion

A randomized, controlled, multicenter clinical study on the treatment of cancer-related fatigue in patients with digestive tract tumors after chemotherapy using Baixiao moxibustion

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078179
Enrollment
Unknown
Registered
2023-11-30
Start date
2023-08-02
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer related fatigue

Interventions

Observation group:Moxibustion of Zusanli, Qihai, and Guanyuan with Baixiao is used. After enrollment, the first 7 days of the first chemotherapy cycle are considered as one course of treatment, and th
Control group:Not treated with Baixiao moxibustion

Sponsors

Jiangsu Province Hospital on Integration of Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: ? Gastrointestinal tumor chemotherapy patients diagnosed with cancer-related fatigue (who have undergone 1 cycle of chemotherapy and have at least 2 more cycles), with a BFI score of = 4; ? Within one week before enrollment, the hemoglobin level was = 80g/L and the absolute count of neutrophils was = 1000/ul; KPS score above 60 points; ? The expected survival period is more than 4 months; ? Patients aged = 18 years and = 85 years old; ? Individuals without strict center of gravity, liver, kidney, or hematopoietic system damage; ? Clear awareness, no intellectual disabilities, able to understand the content of the scale; ? Patients can adhere to moxibustion treatment and sign informed consent forms; ? Patients who have not participated in clinical trials of other drugs or therapies.

Exclusion criteria

Exclusion criteria: ? Patients with fatigue caused by overwork or those who have already experienced fatigue before being diagnosed with cancer; ? In the first 4 weeks before enrollment, there were medication histories of ginseng, methylphenidate, modafinil, phenobarbital, diphenylhydantoin, promidone, butazone, monoamine oxidase inhibitor, clonidine and tricyclic antidepressants; ? Being treated for anemia (such as erythropoietin or blood transfusion); ? The anxiety or depression score in the hospital anxiety and depression scale is greater than 11 points; ? People with diabetes and poor control ? Plan to undergo surgery or radiotherapy during the study period; ? Psychiatric patients who do not cooperate with treatment or patients with a history of repeated falls and falls; ? Pregnant and lactating women; ? People who are allergic to moxa smoke.

Design outcomes

Primary

MeasureTime frame
Brief Fatigue Inventory;

Secondary

MeasureTime frame
Function Assessmentof CancerThempy;Quality of Life Questionnaire;

Countries

China

Contacts

Public ContactHuo Jiege

Jiangsu Province Hospital on Integration of Chinese and Western Medicine

hjg16688@163.com+86 153 1201 9156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026